RE:RE:RE:RE:News out:Trikoka Gone andAnyway, I like the fact that we have a team headed by Dr. Mandel who will remain focused on the primary objective that is to Anti Cancer... I believe TLT will eventually need someone with Medical Device marketing experience to head that part of the business. TLT will need to make the Laser division profitable and possibly spin it off and concentrate on the Core Business of ACT. The Vaccine part of TLD will be supported by the Candian Government funding IMO.
I particularly like the statement from Dr. Mandel being focused on Core objective and above all DELIVER SHARE HOLDER VALUE that has been missing for many years..
"
Dr. Mandel, CSO and Interim CEO of Theralase® stated, “I am honored to return as the Interim CEO for the Company, as the Company realigns its executive management team to focus on the Company’s primary objective of commercialization of its ACT technology, which, if successful, will ultimately deliver shareholder value.”